We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-5.27%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$132M
AUM Growth
-$213M
Cap. Flow
-$204M
Cap. Flow %
-154.6%
Top 10 Hldgs %
46.58%
Holding
55
New
6
Increased
2
Reduced
24
Closed
21

Top Buys

Rank Stock Value
1
WAT icon
Waters Corp
WAT
+$5.13M
2
JNJ icon
Johnson & Johnson
JNJ
+$4.66M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.06M
4
ELV icon
Elevance Health
ELV
+$1.64M
5
CVS icon
CVS Health
CVS
+$1.54M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$9.36M
2
HCA icon
HCA Healthcare
HCA
+$7M
3
MCK icon
McKesson
MCK
+$4.46M
4
MDT icon
Medtronic
MDT
+$4.32M
5
RGEN icon
Repligen
RGEN
+$4.1M

Sector Composition

Rank Sector Weight
1 Healthcare 81.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$19.2M 14.55%
150,000
-75,000
-33% -$9.36M
CAH icon
2
Cardinal Health
CAH
$55.4B
$5.07M 3.85%
24,000
-8,500
-26% -$1.83M
JNJ icon
3
Johnson & Johnson
JNJ
$625B
$4.89M 3.71%
+20,000
New +$4.66M
MRK icon
4
Merck
MRK
$318B
$4.81M 3.65%
40,000
+10,000
+33% +$1.15M
COR icon
5
Cencora
COR
$61.2B
$4.71M 3.58%
15,000
-3,000
-17% -$1.05M
LLY icon
6
Eli Lilly
LLY
$1.06T
$4.6M 3.49%
5,000
-2,000
-29% -$2.03M
WAT icon
7
Waters Corp
WAT
$39.9B
$4.47M 3.39%
+15,000
New +$5.13M
VRTX icon
8
Vertex Pharmaceuticals
VRTX
$126B
$4.46M 3.39%
10,000
-3,770
-27% -$1.76M
ISRG icon
9
Intuitive Surgical
ISRG
$134B
$4.15M 3.15%
9,000
-1,000
-10% -$506K
AZN icon
10
AstraZeneca
AZN
$250B
$3.94M 3%
20,000
– –
TMO icon
11
Thermo Fisher Scientific
TMO
$220B
$3.93M 2.99%
8,000
-4,000
-33% -$2.17M
BSX icon
12
Boston Scientific
BSX
$71.5B
$3.89M 2.95%
62,000
-8,000
-11% -$640K
DHR icon
13
Danaher
DHR
$144B
$3.79M 2.88%
20,000
-3,000
-13% -$639K
THC icon
14
Tenet Healthcare
THC
$21.1B
$3.77M 2.87%
20,000
-17,500
-47% -$3.69M
GILD icon
15
Gilead Sciences
GILD
$165B
$3.48M 2.65%
25,000
– –
HUM icon
16
Humana
HUM
$46.2B
$3.47M 2.63%
20,000
+5,000
+33% +$1.02M
MTD icon
17
Mettler-Toledo International
MTD
$28.6B
$3.47M 2.63%
2,750
-250
-8% -$337K
MCK icon
18
McKesson
MCK
$101B
$3.46M 2.63%
4,000
-5,000
-56% -$4.46M
A icon
19
Agilent Technologies
A
$41.2B
$3.42M 2.6%
30,000
-5,000
-14% -$634K
SYK icon
20
Stryker
SYK
$130B
$3.29M 2.5%
10,000
-3,000
-23% -$1.08M
ABBV icon
21
AbbVie
ABBV
$435B
$3.26M 2.48%
15,000
-5,000
-25% -$1.11M
UHS icon
22
Universal Health Services
UHS
$10.5B
$3.13M 2.38%
17,500
-10,500
-38% -$2.16M
REGN icon
23
Regeneron Pharmaceuticals
REGN
$80.8B
$3.09M 2.35%
+4,000
New +$3.06M
BIO icon
24
Bio-Rad Laboratories Class A
BIO
$9.42B
$2.79M 2.12%
10,000
-2,000
-17% -$576K
BIIB icon
25
Biogen
BIIB
$30.7B
$2.75M 2.09%
15,000
-5,000
-25% -$921K
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q1 2026 Portfolio in Review

As of Q1 2026, Sivik Global Healthcare held 55 positions worth $132M, down 62% from $345M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Sivik Global Healthcare withdrew a net $204M in Q1 2026, closing 21 positions and reducing 24 holdings. Its most notable exit was HCA Healthcare, an estimated $7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, up from 51% a quarter earlier.

Against the trend, Sivik Global Healthcare opened a new position in Waters Corp worth $4.47M.

  • Sivik Global Healthcare's largest Q1 2026 buy was Waters Corp: 15,000 shares worth $4.47M.
  • Sivik Global Healthcare added most to Merck in Q1 2026, an estimated $1.15M increase.
  • Sivik Global Healthcare's biggest Q1 2026 reduction was State Street SPDR S&P Biotech ETF, cutting an estimated $9.36M.
  • Sivik Global Healthcare fully exited HCA Healthcare in Q1 2026, selling an estimated $7M.
  • Sivik Global Healthcare's ten largest holdings make up 47% of its $132M portfolio in Q1 2026.
  • Sivik Global Healthcare opened 6 new positions and closed 21 in Q1 2026.
  • Sivik Global Healthcare's portfolio value fell 62% quarter-over-quarter to $132M.

Based on Sivik Global Healthcare's 13F filing for Q1 2026, filed 15 Apr 2026.